NCT00674752View on ClinicalTrials.gov

A Polysomnographic Study Of Single-Dose Gabapentin In Transient Insomnia

PHASE3CompletedINTERVENTIONAL
Enrollment

377

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

August 31, 2006

Conditions
Transient Insomnia
Interventions
DRUG

Gabapentin

Gabapentin 250 mg oral capsule 30 minutes prior to bedtime

DRUG

Gabapentin

Gabapentin 500 mg oral capsule 30 minutes prior to bedtime

DRUG

Placebo

Matched placebo oral capsule 30 minutes prior to bedtime

Trial Locations (4)

30342

Pfizer Investigational Site, Atlanta

33143

Pfizer Investigational Site, Miami

45227

Pfizer Investigational Site, Cincinnati

66212

Pfizer Investigational Site, Overland Park

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00674752 - A Polysomnographic Study Of Single-Dose Gabapentin In Transient Insomnia | Biotech Hunter | Biotech Hunter